Price movement over the last 24 hours
Advanced Micro Devices vs UnitedHealth Group Inc — how do they compare? Advanced Micro Devices trades at $545.93 (market cap $909.70B), while UnitedHealth Group Inc trades at $424.2 (market cap $385.62B). The key difference: Advanced Micro Devices is far larger — about 2.4× UnitedHealth Group Inc's market cap, and UnitedHealth Group Inc pays a 2.19% dividend while Advanced Micro Devices pays none. Which is the better fit depends on your goals.
| AMD | UNH | |
|---|---|---|
Market Cap | $909.70B | $385.62B |
Sector | Technology | Health |
52-Week High | $580.91 | $431.68 |
52-Week Low | $146.24 | $237.77 |
Enterprise Value | $901.22B | $432.30B |
Dividend Yield | — | 2.19% |
Signals from Pluang's Aura AI — not financial advice
AMD trades at $557.89, up 2.04% today, approaching its 52-week high amid strong AI-driven momentum. The stock shows bullish technical signals with consistent earnings beats and robust revenue growth, reaching $34.64B in 2025. Analyst sentiment remains overwhelmingly positive with a 71.43% buy rating, though valuation metrics like a P/E of 185.96 indicate premium pricing. Cash flow from operations surged to $7.71B in 2025, supporting aggressive investment in AI infrastructure.
Outlook: AMD is well-positioned to capitalize on AI and data center demand, but high valuation and intense competition pose risks. Investors should weigh growth potential against premium multiples, with the consensus price target of $508.24 suggesting near-term caution despite long-term optimism.
UnitedHealth Group (UNH) trades at $424.62, down 1.64% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, including Q1 2026 EPS of $7.23 versus $6.58 expected. Revenue grew to $447.57 billion in 2025, though net income margin compressed to 2.68%. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
UNH presents a favorable risk-reward profile with 82.7% analyst buy ratings and a consensus price target of $423.18, near the current price. Key opportunities include demographic tailwinds from an aging population and tech-driven efficiency gains. Risks involve regulatory scrutiny, as seen in Massachusetts' Medicaid lawsuit, and margin pressure from rising costs. The stock's valuation at a P/E of 31.97 requires sustained earnings growth to justify further upside.
Trailing returns across standard periods
Latest headlines on both assets
Advanced Micro Devices, Inc. (AMD) produces semiconductor products and devices. The Company offers products such as microprocessors, embedded microprocessors, chipsets, graphics, video and multimedia products and supplies it to third-party foundries, as well as provides assembling, testing, and packaging services. AMD serves customers worldwide.
Read more on AMD →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →